PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 65 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,513,310 | -16.4% | 90,726 | +38.4% | 0.00% | 0.0% |
| Q2 2023 | $1,810,215 | -32.1% | 65,540 | -43.5% | 0.00% | 0.0% |
| Q1 2023 | $2,666,597 | +8.4% | 115,939 | -48.6% | 0.00% | 0.0% |
| Q4 2022 | $2,460,521 | +526.1% | 225,529 | +384.2% | 0.00% | – |
| Q3 2022 | $393,000 | -61.5% | 46,580 | -63.9% | 0.00% | – |
| Q2 2022 | $1,020,000 | -64.9% | 128,987 | +5.1% | 0.00% | -100.0% |
| Q1 2022 | $2,907,000 | +28.2% | 122,765 | +85.1% | 0.00% | 0.0% |
| Q4 2021 | $2,268,000 | +85.0% | 66,311 | -4.2% | 0.00% | – |
| Q3 2021 | $1,226,000 | +921.7% | 69,215 | +2491.4% | 0.00% | – |
| Q2 2021 | $120,000 | -89.6% | 2,671 | -94.0% | 0.00% | – |
| Q1 2021 | $1,154,000 | -11.8% | 44,573 | -31.4% | 0.00% | – |
| Q4 2020 | $1,309,000 | +22.9% | 64,933 | +19.2% | 0.00% | – |
| Q3 2020 | $1,065,000 | -12.2% | 54,488 | -20.7% | 0.00% | -100.0% |
| Q2 2020 | $1,213,000 | +134.6% | 68,687 | -6.2% | 0.00% | – |
| Q1 2020 | $517,000 | +247.0% | 73,233 | +246.1% | 0.00% | – |
| Q4 2019 | $149,000 | -25.5% | 21,159 | +27.3% | 0.00% | – |
| Q3 2019 | $200,000 | -84.2% | 16,619 | -84.1% | 0.00% | – |
| Q2 2019 | $1,262,000 | +5909.5% | 104,201 | +6234.4% | 0.00% | – |
| Q1 2019 | $21,000 | +75.0% | 1,645 | -11.7% | 0.00% | – |
| Q4 2018 | $12,000 | -83.6% | 1,863 | -73.6% | 0.00% | – |
| Q3 2018 | $73,000 | -73.6% | 7,055 | -82.8% | 0.00% | – |
| Q2 2018 | $276,000 | +3350.0% | 41,001 | +10467.3% | 0.00% | – |
| Q4 2017 | $8,000 | +60.0% | 388 | +25.6% | 0.00% | – |
| Q3 2017 | $5,000 | -73.7% | 309 | -81.5% | 0.00% | – |
| Q2 2017 | $19,000 | +375.0% | 1,671 | +407.9% | 0.00% | – |
| Q1 2017 | $4,000 | -87.5% | 329 | -77.2% | 0.00% | – |
| Q4 2016 | $32,000 | +39.1% | 1,443 | +35.0% | 0.00% | – |
| Q3 2016 | $23,000 | – | 1,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |